Brief: Protagenic Therapeutics Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
29/11/2023 22:38
Nov 29 (Reuters) - Protagenic Therapeutics Inc PTIX.O :
* PROTAGENIC THERAPEUTICS INC: ON NOV 21, CO RECEIVED NOTICE
OF
DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD FROM NASDAQ
Further company coverage: PTIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Protagenic Therapeutics
See all newsBrief: Protagenic Therapeutics Inc - Alexander Arrow, CFO, To Be Terminated Effective April 30, 2026 - SEC Filing
Brief: Protagenic Therapeutics Approves Restructuring Plan on August 8- SEC Filing
Brief: Protagenic Therapeutics Granted Japanese Patent JP 7714571B
Brief: Protagenic Therapeutics Enters Share Exchange Agreement With Alterola And EMC2 - SEC Filing
Brief: Protagenic Therapeutics - May Offer And Sell, From Time To Time, Shares Of Common Stock Of Up To $1.2 Mln